Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 76.93M | 85.62M | 73.38M | 78.90M | 55.65M | 61.42M |
Gross Profit | 42.05M | 48.53M | 34.01M | 41.08M | 28.34M | 32.68M |
EBITDA | 10.64M | 23.05M | 12.51M | 19.46M | 11.40M | 10.76M |
Net Income | 9.14M | 15.46M | 6.13M | 11.37M | 5.43M | 4.99M |
Balance Sheet | ||||||
Total Assets | 123.55M | 115.97M | 110.58M | 100.95M | 92.94M | 82.94M |
Cash, Cash Equivalents and Short-Term Investments | 97.03M | 91.76M | 79.97M | 65.02M | 62.87M | 63.28M |
Total Debt | 4.66M | 1.54M | 4.24M | 2.46M | 2.69M | 4.58M |
Total Liabilities | 21.09M | 24.79M | 34.16M | 25.64M | 18.93M | 16.16M |
Stockholders Equity | 102.47M | 91.18M | 76.42M | 75.31M | 74.01M | 66.77M |
Cash Flow | ||||||
Free Cash Flow | 5.91M | 13.36M | 21.99M | 14.62M | -286.00K | 6.94M |
Operating Cash Flow | 9.92M | 17.32M | 22.48M | 18.82M | 984.00K | 15.96M |
Investing Cash Flow | -14.84M | -15.21M | -19.97M | -3.98M | -661.00K | -8.54M |
Financing Cash Flow | -3.08M | -2.92M | -6.96M | -12.87M | -2.18M | -1.83M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | HK$44.00M | 4.68 | 9.85% | ― | -7.08% | -23.53% | |
58 Neutral | $1.34B | 4.24 | -2.93% | 7.38% | 3.67% | -51.13% | |
55 Neutral | HK$42.82M | ― | -44.10% | ― | -10.70% | -186.02% | |
46 Neutral | HK$64.35M | ― | -14.12% | ― | 1.24% | -56.85% | |
45 Neutral | HK$33.75M | ― | -80.09% | ― | 8.14% | 70.74% |